Attenuation of epidermal growth factor receptor signaling by the ganglioside G M3 has previously been found to involve activation of an unknown protein-tyrosine phosphatase (PTP). In transient expression experiments we tested dierent PTPs for activation towards EGF receptor by G M3 . The transmembrane PTP RPTPs but not RPTPa or the SH2-domain PTP SHP-1 exhibited elevated activity towards EGF receptor in G M3 -treated cells. The possible relevance of RPTPs for regulation of EGF receptor signaling activity was further explored in stable A431 cells lines inducibly expressing RPTPs or RPTPs antisense RNA. RPTPs expression clearly reduced EGF receptor phosphorylation. Also, soft agar colony formation of respective cell lines was reduced upon RPTPs expression whereas RPTPs antisense RNA expression augmented both, EGF receptor phosphorylation and soft agar colony formation. In addition, RPTPs antisense RNA expression rendered A431 cells resistant to inhibition of EGF receptor phosphorylation by G M3 . We propose that RPTPs participates in EGF receptor dephosphorylation in A431 cells, becomes activated by G M3 via an unknown mechanism and is thereby capable to mediate attenuation of EGF receptor phosphorylation by G M3 .
Introduction
Protein tyrosine phosphatases (PTPs) are believed to participate in signal generation of receptor tyrosine kinases (RTKs), both in positive and negative ways (Neel and Tonks, 1997) . Dephosphorylation of autophosphorylated receptors as well as of downstream signaling molecules has been proposed to prevent ligand-independent signal generation and to ®ne-tune and terminate signals from ligand-activated receptors (Weiss et al., 1997) . Thus, modulation of the activity of RTK-directed PTPs may present a physiological mechanism for regulation of RTKsignaling. Also, identi®cation of receptor-directed PTPs will de®ne new targets for pharmacological interference with receptor hyper-or hypophosphorylation and their consequences. The identity of receptorattenuating PTPs is for most RTKs unknown. Signaling of a number of RTKs has been shown to be negatively regulated by the SH2-domain PTP SHP-1, with best evidence existing for Kit/SCF-receptor (Lorenz et al., 1996; Paulson et al., 1996) and the CSF-1 receptor (Chen et al., 1996) . SHP-1 has also been proposed to participate in dephosphorylation of the EGF receptor in epithelial cells (Tomic et al., 1995) . The picture is emerging, that possibly depending on the cell type and its activation state, multiple PTPs can act on a given RTK. The EGF receptor may be a good example for this: Its dephosphorylation is very rapid with t1/252 min in dierent cells (Faure et al., 1992; BoÈ hmer et al., 1993 BoÈ hmer et al., , 1995 and the list of PTPs shown to possess the capacity for EGF receptor interaction is growing and includes at least PTP1B (Flint et al., 1997; Liu and Cherno, 1997) , PTP-PEST (Charest et al., 1997) , SHP-1 (Tomic et al., 1995; Tenev et al., 1997) and the transmembrane PTP LAR (Kulas et al., 1996) . The functional relevance of these interactions is, however, in most cases not well characterized. In previous investigations we found that the EGF receptor dephosphorylation can be activated by lipids as phosphatidic acid (Tomic et al., 1995) and the ganglioside G M3 (SuaÂ rez Pestana et al., 1997) . While the phosphatidic acid eect seems to be mediated by SHP-1, the possible target PTP for G M3 has been unknown. Here we show, that the transmembrane PTP RPTPs but not SHP-1 can be activated towards the EGF receptor by G M3 in 293 cells. Stable A431 cell lines inducibly expressing RPTPs or an RPTPs antisense RNA exhibited reduced or elevated levels of EGF receptor phosphorylation, respectively. Also, expression of RPTPs antisense RNA increased colony growth of respective A431 cell lines in soft agar and renders EGF receptor phosphorylation insensitive to G M3 treatment. The data are in line with the hypothesis that RPTPs participates in EGF receptor dephosphorylation in certain cell types and plays a role in mediating the G M3 -eect. et al., 1997) , at least in part mediated by activation of EGF receptor dephosphorylation. We tested dierent de®ned PTPs for a possible activation by G M3 towards the EGF receptor. For this, the PTPs were transiently coexpressed with the EGF receptor in 293 cells, the cells were treated with G M3 and EGF and the phosphorylation level of the EGF receptor was subsequently evaluated. We chose SHP-1 and the transmembrane PTPs RPTPs and RPTPa for these experiments. SHP-1 had been implicated earlier in EGF receptor dephosphorylation (Tomic et al., 1995) . Transmembrane PTPs seemed more likely to present targets for G M3 . RPTPs has been found to potently dephosphorylate the EGF receptor and other RTKs (Zhang et al., 1994; Aicher et al., 1997) . Also, RPTPs is upregulated in dense cell cultures and may potentially take part in regulation of density-dependent growth arrest (Celler et al., 1995) . RPTPa is widely expressed (Matthews et al., 1990; Kaplan et al., 1990) and served as a control. To allow judgment of the G M3 treatments, care was taken to express the PTPs to levels which would not lead to complete receptor dephosphorylation on their own.
As depicted in Figure 1b and shown earlier, SHP-1 dephosphorylated the EGF receptor and the extent of dephosphorylation depended on the SHP-1 expression level. However, treatment of the cells with as much as 100 mM G M3 did not enhance the eect of overexpressed SHP-1 towards the receptor. In contrast, RPTPs in the expressed amounts had only a slight eect on EGF receptor phosphorylation (Figure 1a ). Upon treatment of cells coexpressing EGF receptor and RPTPs with G M3 at 25 or 50 mM the receptor phosphorylation level was strongly decreased, whereas treatment of cells overexpressing only EGF receptor with these doses of G M3 had little eect on receptor phosphorylation. RPTPa expression in our hands decreased the expression level of coexpressed EGF receptor in 293 cells (not shown). We therefore judged the eects of RPTPa on the endogenous EGF receptor in COS-7 cells. Under these conditions, RPTPa dephosphorylated the EGF receptor neither in the absence nor in the presence of G M3 (Figure 1c ). This was not due to a lack of activity of RPTPa, since RPTPa expressed to similar levels from the same construct dephosphorylated coexpressed PDGFb receptor and immunoprecipitated RPTPa displayed activity towards a phosphorylated peptide substrate (not shown). Thus, G M3 treatment elevates the activity of RPTPs but not of SHP-1 or RPTPa towards the EGF receptor.
Stable A431 cell lines with inducible expression of RPTPs or RPTPs antisense RNA
The data obtained in transient expression experiments suggested that RPTPs may be a PTP with relevance for regulation of EGF receptor signaling. To further explore this possible relationship, we established stable cell lines in A431 cell background. We chose to make use of the tetracycline expression system for inducible expression of RPTPs to eliminate problems with clonal variation and instead to be able to compare the eects of dierent RPTPs expression levels in the same cell clone. A cDNA coding for the RPTPs variant with eight ®bronectin-like domains (corresponding to RPTPs T (Ogata et al., 1994) ) was cloned into the Figure 1 Eect of the ganglioside G M3 on the activity of RPTPs and SHP-1 towards coexpressed EGF receptor. 293 human embryonic kidney cells were transiently transfected with expression constructs for the EGF receptor and RPTPs (a) or dierent amounts (mgDNA) of an expression construct for SHP-1 (b) as indicated. The cells were mock-treated or treated with G M3 for 2 h and thereafter stimulated with EGF (100 ng/ml, 5 min) or left unstimulated as indicated. Cell lysates were prepared and equal amounts of protein were analysed for EGF receptor phosphorylation and expression levels of EGF receptor and the PTPs by immunoblotting. The running positions of EGF receptor and the PTPs are indicated. Note, that in case of RPTPs the antibody will detect the P-subunit of mature RPTPs (about 80 kDa) and the unprocessed full-length PTP (about 200 kDa). The same blots were stripped and reprobed to allow direct comparison. The lanes in a are rearranged for better clarity but originate from the same blot with identical exposure. (c) COS-7 cells were transiently transfected with dierent amounts (mgDNA) of a CMV-driven expression construct for RPTPa (as indicated) or mock-transfected and were otherwise treated as described above. RPTPa expression was detected in lysates and EGF receptor phosphorylation was analysed after immunoprecipitation tetracycline-regulated expression vector pNRTIS33. This vector harbors all elements of the tetracyclineregulated expression system of Gossen and Bujard (Gossen and Bujard, 1992; Gossen et al., 1994) and drives in the absence of tetracycline derivatives expression of the gene of interest, the tetracyclineinhibited transactivator and aminoglycoside phosphotransferase from a tricistronic mRNA (Tenev et al., in preparation) . This RPTPs expression construct designated pNRTIS33/RPTPs was used for generation of stable cell lines. In Figure 2 expression analysis for selected cell lines is shown. As all members of the type IIA family of receptor-like PTPs (Schaapveld et al., 1997a) , RPTPs is synthesized as a precursor and subsequently processed into two non-covalently associated subunits designated E-and P-subunit. The former represents largely the glycosylated extracellular domain, the latter the cytoplasmic part, the transmembrane domain and a short extracellular piece (Aicher et al., 1997) . Both, the E-and P-subunit of RPTPs (150 Figure 2 Expression analysis of RPTPs in A431 cell lines. A431 cells (ATCC CRL 1555) were transfected with an RPTPs construct in the vector pNRTIS33 allowing inducible expression under control of tetracycline. Alternatively, cells were transfected with the same vector harboring the RPTPs cDNA in 3'-5' orientation to allow expression of an RPTPs antisense RNA or with the empty vector (`mock'). Results are shown for RPTPs expressing clones s2, s3, s5, RPTPs antisense RNA expressing clones a1 and a5 and mock-transfected clones K2 and K3. The cell lines were grown in the presence of ATc (100 ng/ml,`+', suppressed state) or absence of ATc (`7', induced state) for 5 days. (a) Cell lysates (about 1 mg protein) were subjected to immunoprecipitation with an antibody recognizing an epitope in the C-terminus of RPTPs and LAR (anti-RPTPs/LAR). Mock precipitations were carried out with protein A beads alone (`-Ab'). The immunoprecipitated proteins were subjected to SDS ± PAGE and immunoblotting. A431 cell lines as indicated were grown in the absence or presence of ATc and total RNA was isolated and subjected to RT ± PCR as described under Materials and methods. Primers speci®c for human RPTPs DNA and human GAPDH resulted in ampli®ed fragments of 441 bp (lanes 2, 3, 9 and 10) and 399 bp (lanes 4, 5, 11 and 12), respectively. Lanes 6 and 13: positive control (323 bp product, template provided by the manufacturer); lanes 7 and 14: negative control (reagents, no template); lane 1, 8 ± 100 bp standard ladder 2a). In 293 cells overexpressing RPTPs an approximately 200 kDa band is visible in addition, representing RPTPs not processed into E-and P-subunit. For all immunoprecipitations we used an antibody against the C-terminus of RPTPs which cross-reacts with the closely related PTP LAR. Immunoblotting with the same antibody, therefore, visualizes the P-subunit of endogenous LAR which is slightly bigger than the RPTPs P-subunit (Aicher et al., 1997) . In contrast, the endogenous RPTPs cannot be visualized by immunoprecipitation and subsequent immunoblotting with the reagents employed. Inducible RPTPs expression can also be demonstrated by immunoprecipitation from 35 Smethionine labeled A431 cell clones (Figure 2b ). Endogenous LAR can clearly be seen in immunoprecipitates from these cells as an approximately 150 kDa (E-subunit) band and a band somewhat bigger than 80 kDa (P-subunit). An approximately 80 kDa band representing the P-subunit of RPTPs appears upon ATc-withdrawal in pNRTIS33/RPTPs-transfected cells. Also, intensity of the 150 kDa band is increased since it now represents both endogenous LAR and induced RPTPs E-subunit. All these bands are not seen if the peptide used for immunization was included in the immunoprecipitation. A very weak band migrating in the position of the P-subunit of RPTPs in mocktransfected or ATc-treated cells and being competed by the peptide may represent endogenous RPTPs, however, an assignment was dicult to make given the low signal intensity. Expression of endogenous RPTPs could, however, be clearly demonstrated on the mRNA level by RT ± PCR (Figure 3c ). In addition to inducible overexpression of RPTPs we intended to study the eect of inducible expression of an RPTPs antisense RNA. We expected that a construct based on the murine RPTPs cDNA would work for the desired purpose in the human host cell line, since human and murine RPTPs exhibit a high degree of sequence identity, both on amino acid and nucleotide level. Murine RPTPs cDNA has previously been successfully used as a hybridization probe for human RPTPs gene sequences under high stringency conditions (Wagner et al., 1996) . The RPTPs cDNA was cloned in 3'-5' orientation into pNRTIS33. We tested the functionality of this construct designated pNRTIS33/RPTPs-antisense in terms of suppression of RPTPs expression in transient experiments. We judged the eect on constitutive RPTPs expression from a cotransfected RPTPs cDNA in a CMV-driven expression vector (pcDNA3/RPTPs VSV). As shown in Figure 3a , the expression of RPTPs was strongly reduced when the RPTPs antisense RNA expression was induced (-ATc), whereas cotransfection of pNRTIS33/RPTPs-antisense with pcDNA3/RPTPs VSV had little eect on RPTPs expression in the presence of ATc. In the same setup, the expression of the unrelated PTP RPTPa was not aected by induction of RPTPs antisense RNA expression (Figure 3a) . Reprobing of the same blot with anti-vinculin antibodies veri®ed comparable loading of all lanes (Figure 3a, lower panel) . Stable A431 cell clones transfected with pNRTIS33/RPTPsantisense were obtained. While from the reasons outlined above it was dicult to judge the eect of RPTPs antisense RNA expression on endogenous RPTPs in immunoblots or in immunoprecipitates from 35 S-labeled A431 cells stably transfected with pNRTIS33/RPTPs-antisense, the level of expression of endogenous PTP LAR was apparently unaected by induction of RPTPs antisense RNA expression (Figure 2a, b) . To obtain direct evidence for the eect of RPTPs antisense RNA expression on endogenous RPTPs levels, we ®rst analysed PTP activity towards a synthetic phosphopeptide in immunoprecipitates from the stably transfected cell lines. The antibody employed for these immunoprecipitations precipitates both RPTPs and the PTP LAR. Whereas the same level of Figure 4 Eect of RPTPs expression level on EGF receptor phosphorylation in A431 cell clones. The dierent A431 cell clones (as indicated) were grown in the absence (`7', induced state) or presence (`+', suppressed state) of 100 ng/ml ATc as indicated. Lysates were prepared and equal amounts of lysate protein (20 mg) were analysed for tyrosine phosphorylation and EGF receptor loading (identical blot stripped and reprobed). Note that identical signals for EGF receptor loading are detectable in the compared+ATc lanes for the same cell lines whereas loading between dierent cell lines is somewhat dierent. A duplicate experiment is shown, which is representative for data obtained in multiple experiments with at least three cell clones of each type. All tracks originate from the same blot with identical exposure but the blot is rearranged for better clarity PTP activity was detected in precipitates from mocktransfected cells in absence or presence of ATc, immunoprecipitates from pNRTIS33/RPTPs-antisense transfected cells cultured in absence of ATc contained less PTP activity than immunoprecipitates obtained from cells cultured in presence of ATc (Figure 3b ). Although the dierences were relatively small, they were statistically signi®cant. The reverse eect was seen with cells exhibiting inducible expression of RPTPs. It seems likely that the observed changes represent changes of RPTPs expression since the PTP LAR level is not changed in dependence on ATc in any of the cell lines. To obtain further direct evidence for the downmodulation of endogenous RPTPs levels in the A431 cell lines upon expression of the RPTPs antisense RNA, we evaluated the mRNA levels of endogenous RPTPs by RT ± PCR. Using primers which speci®cally amplify a DNA fragment from human RPTPs but do not recognize murine RPTPs DNA as a template (not shown), a clear decrease of endogenous (human) RPTPs mRNA was detectable upon induction of (murine) RPTPs antisense RNA (Figure 3c , lanes 9 and 10). No change of RPTPs mRNA level was seen under the same conditions in mock-transfected cells (lanes 2 and 3) and no change in mRNA expression of the housekeeping enzyme GAPDH was detected with identical template samples (Figure 3c , lanes 11 and 12) upon induction of RPTPs antisense RNA.
A B
RPTPs expression level aects EGF receptor phosphorylation, G M3 -susceptibility and A431 cell soft agar growth
The cell lines with inducible overexpression of RPTPs or inducible expression of RPTPs antisense RNA were subjected to analysis of EGF receptor phosphorylation level. As depicted in Figure 4 , EGF receptor phosphorylation was unaected by ATc-treatment in mocktransfected cells. RPTPs-induction clearly reduced the level of phosphorylation of the EGF receptor and of other proteins which are phosphorylated in an EGFdependent manner. In contrast, pNRTIS33/RPTPsantisense transfected cells always exhibited a small but very reproducible increase in EGF receptor phosphorylation and in phosphorylation of other proteins upon induction of RPTPs antisense RNA expression ( Figure  4 , compare also Figure 5a ). These data are in agreement with a negative eect of RPTPs on EGF receptor phosphorylation in A431 cells.
We also tested the eect of G M3 on EGF receptor phosphorylation in the stably transfected cell lines. In mock-transfected cells, in RPTPs-transfected cells and in cells transfected with pNRTIS33/RPTPs-antisense treated with ATc we observed a partial inhibition of EGF receptor phosphorylation by G M3 (Figure 5a ) which was indistinguishable in extent and doseresponse in these cases, given the limitations of experimental error in these experiments (Figure 5b ). In cells expressing RPTPs antisense RNA (pNRTIS33/RPTPs-antisense transfected cells in the absence of ATc) EGF receptor phosphorylation was resistant to inhibition by G M3 . This ®nding is in agreement with the concept that RPTPs is required for mediating G M3 inhibition. We did, however, not observe an enhanced response to G M3 in the RPTPs overexpressing cell lines (Figure 5b) . One possible explanation could be that the endogenous level of RPTPs in A431 cells is sucient for mediating a maximal G M3 response.
In order to test possible biological consequences of RPTPs expression we chose to analyse soft agar colony forming capacity of the dierent cell clones. Whereas EGF exerts a negative eect on monolayer growth of A431 cells, EGF stimulates growth of A431 cell colonies in soft agar (Lee et al., 1987) and inhibition of EGF receptor signaling has been shown to lead to reduced colony forming activity of EGF receptor overexpressing cells (Fry et al., 1997) . The cloning activity of the dierent stable A431 cell lines in the presence of ATc was variable, probably representing clonal variation rather than eects of transgene leakage. Interestingly, upon induction of RPTPs expression we observed a decrease in colony forming A B Figure 5 Eect of RPTPs expression on the susceptibility of A431 cells to inhibition of EGF receptor autophosphorylation by G M3 . (a) A431 cell clones (as indicated) were grown in the absence or presence of ATc and treated for 2 h with the indicated amounts of G M3 . Thereafter, the cells were stimulated with EGF (100 ng/ml, 5 min) or left untreated, were lysed and equal amounts of lysate protein were analysed by SDS ± PAGE and immunoblotting. Equal loading was veri®ed by anti-EGF receptor blotting (not shown). (b) The blots were subjected to densitometric scanning and EGF receptor phosphorylation is plotted relative to the one in cells not treated with G M3 (100%). G M3 does not completely inhibit EGF receptor phosphorylation. Note that, to make the dierences better visible, the ordinate, therefore, does not start at 0 capacity and the opposite eect was observed upon expression of RPTPs antisense RNA (Figure 6a and  b) . Thus, the eects of RPTPs levels on EGF receptor phosphorylation seem to become translated into eects on A431 cell colony growth.
Discussion
The data presented in this paper suggest that the transmembrane PTP RPTPs participates in dephosphorylation of the EGF receptor. Our proposal of a role for RPTPs in EGF receptor regulation is based not solely on RPTPs overexpression but also on suppression of endogenous RPTPs by antisense experiments. One has, however, to make the reservation that the speci®city of RPTPs suppression has been tested only in comparison to LAR and RPTPa and it is dicult to exclude suppression of expression of other PTPs which were not tested or which are not yet identi®ed. Also, RPRPs overexpression or expression of RPTPs antisense RNA could theoretically lead to unrelated non-speci®c eects, ultimately both resulting in modulation of EGF receptor signaling in an opposite manner. This possibility, although not very likely, cannot be completely excluded.
RPTPs is a member of the type IIA family of receptor-like PTP comprising at least two further members, LAR and PTPd (Schaapveld et al., 1997a) . The PTPs in this family exhibit extracellularly structural features characteristic of adhesion molecules and reveal a high degree of homology to each other suggesting that they may partially be redundant with respect to function. This assumption is supported by the ®nding that mice with an inactivated LAR gene are viable and have a more subtle phenotype in mammary gland development (Skarnes et al., 1995; Schaapveld et al., 1997b) . On the other hand, the PTPs in this family exist in multiple isoforms arising by alternative splicing, suggesting possibly very speci®c functions in dierent cell types or developmental stages (Longo et al., 1993; Ogrady et al., 1994; Rotin et al., 1994; Zhang and Longo, 1995; Pulido et al., 1995a) . RPTPs has previously been shown to have the capacity for EGF receptor dephosphorylation in vitro and in transient coexpression experiments (Zang et al., 1994; Aicher et al., 1997) . The PTP LAR has been suggested to participate in dephosphorylation of insulin receptor and also EGF receptor (Kulas et al., 1995 (Kulas et al., , 1996 . A type II PTP in C. elegans, CLR-1 has by genetic evidence been identi®ed as a negative regulator of the C. elegans FGF-receptor homologue EGL-15 signaling (Kokel et al., 1998) . RPTPs is highly expressed in brain and widely expressed in other tissues, overlapping with EGF receptor expression, however, low expression has been reported for the EGF receptor-rich tissues liver and placenta (Walton et al., 1993; Yan et al., 1993; Ogata et al., 1994; Zhang et al., 1994; Pulido et al., 1995b; Norris et al., 1997) . Thus, the expression pattern and our ®ndings would be consistent with a function of RPTPs for EGF receptor regulation in some but not all EGF receptor expressing cell types. One could speculate that other members of the family take part in EGF receptor modulation in cell types where RPTPs is not expressed. It has to be clari®ed by future work to what extent the ®ndings we obtained in 293 and A431 cells highly overexpressing EGF receptors can be generalized.
Further support for RPTPs being involved in EGF receptor dephosphorylation comes from the observation that the previously known attenuation of EGF receptor phosphorylation by G M3 (Bremer et al., 1986 ; SuaÂ rez Pestana et al., 1997) can be reconstituted in 293 cells in an RPTPs dependent manner. Also, A431 cells expressing RPTPs antisense RNA were resistant to the action of G M3 . Thus G M3 is apparently able to activate RPTPs towards autophosphorylated EGF receptors in intact cells. So far, there is to our knowledge no other example yet for activation of a type IIA PTP by an extracellular agent. The mechanistic basis for the observed eect is not known. We were unable to activate immunoprecipitated RPTPs by G M3 in vitro or to recover activated RPTPs from G M3 -treated 293 cells (SuaÂ rez Pestana, unpublished data) suggesting that the membrane environment is required to enable RPTPs activation. One could speculate that G M3 mimics an activating ligand for RPTPs or aects PTP activity by inserting in the membrane. It is, alternatively, possible that the G M3 eect is indirect and involves activation of unknown signaling steps which in turn lead to elevation of RPTPs activity or a better access of the PTP to the EGF receptor. It is likely, that activity of type IIA PTPs is regulated in a complicated manner given the complexity of interaction with intracellular proteins as TRIO (Debant et al., 1996) and Liprins (Serra-Pages et al., 1995 which has recently been revealed by protein ± protein interaction studies. G M3 could aect these yet unde®ned pathways.
In our experiments RPTPs expression level was inversely correlated with the colony forming capacity of respective A431 cell lines. Thus, RPTPs exhibits an anti-transforming eect in this setting. Transformation driven by tyrosine kinase type oncogenes has previously been shown to become suppressed by other PTPs as PTP1B (Brown-Shimer et al., 1992) , TC-PTP (Lammers et al., 1993) and LAR (Zhai et al., 1995) . The PTP MEG has been shown to reduce soft agar colony forming capacity of COS-7 cells (Gu et al., 1996) . Further, the transmembrane PTP DEP-1 induces growth inhibition and dierentiation in mammary carcinoma cell lines (Keane et al., 1996) . Genetic evidence suggests a role of the PTP PTEN as a tumor suppressor (Li et al., 1997) . Our data add a further example to support the general concept that PTPs can act anti-transforming by antagonizing tumor-associated hyperphosphorylation on tyrosine residues. Since colony forming capacity of A431 cells appears to relate to the high level overexpression of the EGF receptor in these cells, it seems tempting to speculate that the eects of RPTPs expression levels on colony growth are the consequence of the negative regulation of EGF receptor signaling. Alternatively, RPTPs may have additional eects on colony growth via distinct targets. Recently, overexpression of the PTP LAR in ®broblasts has been shown to result in apoptosis by an unknown mechanism (Weng et al., 1998) . The availability of cell lines with inducible expression of RPTPs will enable identi®cation of further possible targets for this PTP.
Materials and methods

DNAs and antibodies
cDNAs for the human EGF receptor and the PTP SHP-1 (human) in the CMV promoter-driven expression vector pRK5 were kindly provided by Drs A Ullrich and R Lammers (Martinsried). A cDNA for murine RPTPa (LRP) was kindly provided by Dr ML Thomas (St. Louis). An expression construct for PTP RPTPa in a VSV-tagged form (pRK5/RPTPa VSV) was generated as described elsewhere (Groû et al., submitted) . The cDNA for RPTPs (clone`T' as described earlier (Ogata et al., 1994) ) was subcloned ®rst into pRK5 using SalI restriction. For further modi®cation, the DNA was subcloned in two parts into pBluescript KS (Stratagene, Heidelberg). The untranslated 5' and 3' sequences were removed from these pieces by PCR amplifying (Expand TM , Boehringer Mannheim) the coding sequences only using appropriate primers and subcloning the resulting fragments again into pBluescript. The full-length RPTPs cDNA was subsequently reassembled in the expression vector pcDNA3 (Invitrogen, Leek) to give pcDNA3/RPTPs. For introduction of a sequence coding for the VSV-G epitope tag, a SacI place preceding the stop codon was created by PCR and the VSV-tag sequence was transferred into this construct from SacI-digested RPTPa/ pRK5-VSV resulting in pcDNA3/RPTPs ± VSV. In order to generate a construct for inducible expression of RPTPs or RPTPs antisense RNA, the tricistronic inducible vector pNRTIS33 (Tenev et al., in preparation) was used. This inducible expression vector is regulated by a tetracycline responsive promoter (Gossen and Bujard, 1992) and includes the cloning site (EcoRI), the aminoglycoside transferase (Neo resistance) gene and the tetracycline transactivator gene (Gossen and Bujard, 1992) joined by two internal ribosomal entry sites (IRES). The components of the original tetracycline-regulated expression system were generously provided by Dr H Bujard (Heidelberg). The RPTPs cDNA in pcDNA3/RPTPs was¯anked with EcoRI sites at both ends and subsequently transferred into pNRTIS33 in both orientations, 5'-3' to give pNRTIS33/RPTPs and 3'-5' to give pNRTIS33/RPTPs-antisense. Details of the cloning procedure and sequences of the used oligonucleotides are available on request. All constructs were veri®ed by DNA sequencing and by transient expression analysis in human embryonal kidney 293 cells and COS-7 cells.
Polyclonal rabbit anti-phosphotyrosine antibodies and a monoclonal antibody against RPTPa were from Transduction Laboratories (Lexington). Rabbit polyclonal IgG recognizing the human EGF receptor at residues 1005 ± 1016 and rabbit IgG against a carboxyterminal sequence of SHP-1 were from Santa Cruz Biotechnology (Santa Cruz). Monoclonal antibodies against the VSV-G epitope were obtained from Sigma (Deisenhofen). An antiserum designated 322 against an N-terminal peptide sequence in RPTPs and speci®cally recognizing RPTPs but not the PTP LAR (Aicher et al., 1997) was generously provided by Dr A Ullrich (Martinsried). An antiserum against the carboxyl terminal peptide sequence AALEYLGSFDHYAT of RPTPs was raised in rabbits and speci®c antibodies were anity purified using sequential chromatography over protein A Sepharose (Pharmacia, Uppsala) and the peptide covalently coupled to Actigel ALD (Sterogene, Carlsbad). The monoclonal antibody 425 against the extracellular domain of human EGF receptor was kindly provided by Dr A Luckenbach (E Merck, Darmstadt).
Other reagents
Human recombinant EGF was provided by the Center of Genetic Engineering and Biotechnology of Havana, Cuba. G M3 ganglioside was puri®ed as described earlier (SuaÂ rez Pestana et al., 1997) and kindly provided by Dr LE FernaÂ ndez (Havana). For use, G M3 was dissolved in PBS by sonication and then passed through a 0.2 mM sterile ®lter. Anhydrotetracyline (ATc) was from Acros (Geel).
Transfections and generation of stable cell lines
All cell lines were grown in DMEM, supplemented with sodium pyruvate, glutamax TM , 4.5 g glucose/1 and 10% fetal bovine serum. All cell culture reagents were from Life Technologies (Eggenstein).
Transient transfections were carried out using human embryonal kidney 293 cells (CRL 1573, ATCC, Rockville) or COS-7 cells (ACC60, German Collection of Microorganisms and Cell Cultures, Braunschweig) as described (Lammers et al., 1993; Tomic et al., 1995) .
Stable transfections of A431 human epidermoid carcinoma cells (CRL 1555, ATCC, Rockville) were performed using the Superfect TM transfection kit (Quiagen, Hilden) according to the protocol of the manufacturer using non-linearized pNRTIS33/RPTPs, pNRTIS33/RPTPs-antisense or pNRTIS33 vector DNA, yielding cell lines designated A431sn (`RPTPs sense'), A431an (`RPTPs antisense') A431Kn (`mock'), respectively. Cells were selected in the absence of ATc and in the presence of 0.8 mg/ml G418 (Life Technologies, Eggenstein) and individual clones were picked, expanded and analysed after about 6 weeks.
Expression and phosphorylation analysis
To detect various proteins in transiently transfected cells, extracts were prepared with lysis buer (10 mM HEPES (pH 7.5), 150 mM NaCl, 1% Triton X-100, 10 mM Na 4 P 2 O 7 , 50 mM NaF, 2 mM zinc Acetate, 2 mM EGTA; freshly added 1 mM PMSF, 2 mM Na 3 VO 2 , 5 mg/ml leupeptin) and normalized amounts of protein (20 mg per lane) were directly analysed by immunoblotting as described earlier (Tomic et al., 1995) . To monitor EGF receptor phosphorylation, cells were treated overnight with serum-free medium. The medium was changed and the desired agents were added as described in the ®gure legends. The cells were stimulated with 100 ng/ ml EGF for 5 min at 378C. Cell extracts were prepared as described (Tomic et al., 1995) and normalized protein amounts were analysed directly by immunoblotting with anti-phosphotyrosine antibodies or subsequent to immunoprecipitation using anti-EGF receptor antibody 425 as described (SuaÂ rez Pestana et al., 1997) . To evaluate inducible PTP expression in stably transfected cells, the cells were grown for 5 days in the absence or presence of ATc (100 ng/ ml). Equal amounts of cell extract protein (about 1 mg) were subjected to immunoprecipitation with 5 mg anity-purifed anti-RPTPs/LAR antibody in lysis buer for 2 h at 48C. The precipitated proteins were analysed by SDS ± PAGE and immunoblotting using the same antibody (4 mg/ml) or antiserum 322 (1 : 1000). Alternatively, cells were grown to subcon¯uence and labeled with 32 S-methionine (50 ± 100 mCi/ ml) overnight in methionine-free medium supplemented with 10% dialyzed fetal bovine serum. Cell extracts corresponding to equal amounts of acid-insoluble radioactivity (10 ± 20610 6 c.p.m.) were subjected to immunoprecipitation in the absence or presence (50 mg/ml) of the peptide used for immunization. Immunoprecipitates were analysed by SDS ± PAGE and¯uorography of Entensify TM (NEN Life Sciences, Zaventem) treated gels.
For PTP assays, cell extracts were prepared in the absence of phosphatase inhibitors in the lysis buer and immunoprecipitation was done as above. PTP activity was assayed in aliquots of the immunoprecipitates with [
32 P]Raytide as described earlier (Tomic et al., 1995) .
To monitor mRNA levels of endogenous human RPTPs in the A431 cell lines, total RNA was prepared from cells grown in the absence or presence of anhydrotetracyline using the RNeasy Kit (Quiagen, Hilden) and RT ± PCR was carried out with the Access RT PCR System (Promega, Madison) according to the instructions of the manufacturer using approximately 0.2 mg total RNA per reaction. For detection of human RPTPs the primers 5'-CGGAGATCG-GAGGTCGCTGCCAAG-3' (forward, annealing in a part of the 5' untranslated region with little homology between human and murine RPTPs sequence) and 5'-ATGTC-GATGTTGGGGAAGCCAGAG-3' (reverse, mismatch with murine RPTPs sequence in three positions) were used resulting in ampli®cation of a 441 bp DNA fragment corresponding to the human RPTPs DNA sequence (GenBank U35234) from bp 84 ± 524. For a reference, a 399 bp DNA fragment from the sequence of human GAPD-H was ampli®ed from identical amounts of the same RNA samples using the primers 5'-GCG TCG CCA GCC GAG CCA CA-3' (forward) and 5'-GGG GCA TCA GCA GAG GGG GC-3' (reverse).
Colony growth in semi-solid agar
A top layer of 0.5 ml 0.25% agar (Difco, Detroit, MI, USA), DMEM, 10% FCS, and 10 mM HEPES (pH 7.4), with or without ATc (200 ng/ml) containing a single cell suspension of 2610 4 cells was added to a 0.5 ml bottom layer of 0.25% agar, DMEM, 10% FCS, and 10 mM HEPES in each of the inner eight wells of a 24 well plate. The remaining wells of the plate were ®lled with sterile PBS, and the plates were incubated at 378C in a humidi®ed 7.5% CO 2 incubator for 2 weeks. The colonies were stained with MTT (3-[4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide], 500 mg/ml, Sigma, Deisenhofen) for 2 ± 3 h and subsequently all colonies in each well were counted under the microscope. All assays were done in quadruplicates.
